SKY-0515

· Skyhawk Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SKY-0515, covering 2026-04-21 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: An Extension of SKY-0515 in Participants With Huntington's Disease [Phase 2, Phase 3]